MIT Enterprise Forum Names Richard Kivel as New Global Chair

Luke Timmerman7/9/08

The MIT Enterprise Forum, a networking organization for entrepreneurs, said today that Richard Kivel has been named as chairman of its global board of directors. Kivel, a member of the Enterprise Forum’s board since 2006, is the CEO of TheraGenetics, a personalized medicine company based in London. He replaces Joe Hadzima, managing director of Main Street Partners, a venture development and commercialization firm in Cambridge, MA.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.